We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
All essential shared data assets (ESDA) must be assessed for data quality issues, made findable and be available through APIs.
An overview of the work the IPO is undertaking in relation to Standard Essential Patents.
How responders can reduce the risk of communications disruption during emergencies by using ResilienceDirect, HITS and Telecoms Sub-Groups.
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
Apply to manufacture Extemporaneous preparations, Autogenous vaccines, authorisations for Equine Stem Cell Centre (ESCCA) or Non-Food Animal Blood Bank (NFABBA).
Essential elements for implementation of the family origin questionnaire (FOQ) to help assess if a person is a likely carrier for sickle cell and thalassaemia (SCT).
Guidance for staff of responder agencies, particularly senior officers or managers involved in emergency response and recovery preparations.
Information on enhancing communications resilience and how we work with telecommunication service providers to manage the risk of disruption to public networks.
Researchers around the world will soon be able to access millions of the natural, historic specimens found in UK museums at the click of a button as part of a £473 million UK fund to enhance key research infrastructure.
Guidance for organisations when making decisions about the design and operation of enterprise IT services which handle OFFICIAL information.
Information on the programme, including the screening tests, commissioning, quality assurance, education and training.
Advice for people who commission, fund, deliver and evaluate health outreach programmes.
How to get a marketing authorisation for an Advanced Therapy Medicinal Product (ATMP) so it can be sold and/or supplied in Great Britain.
SEPs are of growing importance to the UK economy. The IPO is committed to ensuring the current SEPs framework functions effectively to encourage innovation and promote competition.
Policy and supporting guidance for departments on Essential Shared Data Assets and Data Ownership in Government.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.